FDA’s Real-Time Clinical Trial Push: What It Could Mean for Patients
The FDA took two April 2026 steps that could matter to patients: it advanced early real-time clinical trial work and reminded more than 2,200 sponsors and researchers to report overdue results. The changes may improve transparency and speed up research, but they do not replace careful evidence review.
